Jan 31, 2024, 08:28 AM by

Vector Laboratories and Navinci Diagnostics announced that they have signed an agreement to develop cutting-edge biomarker discovery tools, allowing detection of specific protein glycosylation in tissue samples.

Jan 31, 2024, 08:28 AM by

Jan 31, 2024, 08:28 AM by

Qlucore, a leader in software development for precision cancer diagnostics, has taken the final major step in the process towards a CE-marked medical device for in-vitro diagnostics by submitting the technical documentation to a Notified Body. The CE marked product, Qlucore Diagnostics, is due to be launched in February 2025.

Jan 31, 2024, 01:00 AM by User Not Found

Bio-IT World | Illumina Ventures Labs is now operational and finalizing agreements with several startup companies; Oxford Nanopore Technologies and Guy’s and St Thomas’ NHS Foundation Trust have successfully completed a pilot program meant to deliver a respiratory metagenomics service with an integrated respiratory infection and biosecurity application; The Pistoia Alliance has appointed Dr. Christian Baber as its new Chief Portfolio Officer; more.

Jan 30, 2024, 08:50 AM by

The COVID-19 pandemic has acted as a catalyst for the integration of AR and VR technologies in the healthcare industry. From training healthcare professionals to addressing staff shortages, educating patients, and facilitating treatment and rehabilitation, these immersive technologies have proven their worth in navigating the complexities of the ongoing global health crisis. As the world continues to grapple with the challenges posed by the pandemic, the role of AR and VR in healthcare is likely to evolve and expand, ushering in a new era of innovation and resilience in the face of health emergencies.

Jan 30, 2024, 08:50 AM by

Jan 30, 2024, 08:50 AM by

Jan 30, 2024, 01:00 AM by User Not Found

Bio-IT World | The University of New England has received an award from the National Institutes of Health to support an Institutional Development Award Center of Biomedical Research Excellence to be named the UNE Center for Cell Signaling Research; Motif Neurotech has secured a Series A financing for the development of lead product, DOT microstimulator; Ex-Nvidia exec launches and intends to further develop AI platform RagaAI; more.

Jan 29, 2024, 08:34 AM by

Jan 29, 2024, 08:34 AM by

Jan 29, 2024, 08:34 AM by

Jan 29, 2024, 08:34 AM by

CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.

Jan 29, 2024, 08:34 AM by

Drug discovery specialists Cresset have just released a new version of their drug discovery platform Flare.

Jan 26, 2024, 08:48 AM by

Recognizing the critical role of artificial intelligence in accelerating drug discovery, Bio-IT World Conference & Expo is offering expanded content on this pivotal technology at its 23rd annual event.

Jan 26, 2024, 08:48 AM by

Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board

Jan 26, 2024, 08:48 AM by

Jan 26, 2024, 08:48 AM by

Jan 26, 2024, 08:48 AM by

Jan 26, 2024, 08:48 AM by

MedPharm, Ltd. is announcing the addition of Daniel Morland to its Senior Leadership Team as Senior Director of Sales & Marketing. Dan has more than 15 years of experience in the pharmaceutical industry and will be based out of the company's Headquarters in Guildford, UK. He will directly oversee MedPharm's global commercial efforts.

Jan 25, 2024, 09:01 AM by

Amerigo Scientific is pleased to announce the availability of their well-selection and high-quality optimized ELISA kits designed to accurately measure target-specific proteins with simplicity, reliability, and consistency.